New research from Olio Labs, using Truveta Data, reveals that women experience nausea and vomiting at significantly higher rates than menand uncovers biological reasons why
The input agreed that discontinuation should be considered if a decrease of 5% or greater in weight or baseline BMI has not been achieved, during pregnancy and/or breastfeeding, or if the patient experiences a lack of response, side effects, or renal impairment, or has a contraindication to setmelanotide
R.JeongW
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports
Figure 3 depicts the estimated heritabilities: GSH, 57 %